Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/CIPLA stock hub

NSE/CIPLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/CIPLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1T

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/CIPLA

In the news

Latest news · NSE/CIPLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.6

P25 24.9P50 32.4P75 45.7

Trailing P/E23.9

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC17.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/CIPLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

INR

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	30,313
Employees Change	2,549%
Employees Change Percent	9.18
Enterprise value	INR 987.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE059A01026
Last refreshed	2026-05-10
Market cap	INR 1.1T
Price	INR 1,348
Price currency	INR
Rev Per Employee	9,226,137.3x
Sector	Healthcare
Sic	2834
Symbol	nse/CIPLA
Website	https://www.cipla.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.18%
EV Earnings	21.73x
EV/EBIT	18.21x
EV/EBITDA	15.32x
EV/Sales	3.53x
Forward P/E	27.61x
P/B ratio	3.29x
P/E ratio	23.95x
P/S ratio	3.89x
PE Ratio10 Y	30.88x
PE Ratio3 Y	26.06x
PE Ratio5 Y	28.08x
PEG ratio	4.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.44%
EBITDA Margin	22.77%
Gross margin	65.19%
Gross Profit	INR 182.3B
Gross Profit Growth	2.97%
Gross Profit Growth Q	-7.8%
Gross Profit Growth3 Y	10.02%
Gross Profit Growth5 Y	9.65%
Net Income	INR 45.5B
Net Income Growth	-8.88%
Net Income Growth Q	-56.97%
Net Income Growth Years	8%
Net Income Growth3 Y	19.89%
Net Income Growth5 Y	15.23%
Pretax Margin	21.49%
Profit Margin	16.26%
Profit Per Employee	INR 1.5M
Profitable Years	22
Roa5y	9.48
Roe5y	14.77
ROIC	17.92
Roic5y	17.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.36%
Cagr15y	11.07%
Cagr1y	-9.71%
Cagr20y	8.99%
Cagr3y	14.41%
Cagr5y	9.65%
Div CAGR10	23.11%
Div CAGR3	23.47%
Div CAGR5	26.19%
EPS Growth	-8.9
EPS Growth Q	-57.02
EPS Growth Years	8
EPS Growth3 Y	19.85
EPS Growth5 Y	15.21
Revenue Growth	4.67x
Revenue Growth Q	0.02x
Revenue Growth Quarters	14x
Revenue Growth Years	10x
Revenue Growth3 Y	7.97x
Revenue Growth5 Y	8.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 106B
Debt	INR 4.7B
Debt EBITDA	INR 0.07
Debt Equity	INR 0.01
Equity	INR 330.2B
Interest Coverage	145.8
Net Cash	INR 101.3B
Net Cash By Market Cap	INR 9.31
Net Cash Growth	22.89%
Net Debt EBITDA	INR -1.59
Net Debt Equity	INR -0.31
Tangible Book Value	INR 275.5B
Tangible Book Value Per Share	INR 341
WACC	4.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	23.08%
Dividend Growth Years	3%
Dividend per share	INR 13
Dividend Years	25
Dividend Yield	0.97%
Ex Div Date	2025-06-27
Last Dividend	INR 16
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	167.85%
1Y total return	-9.7%
200-day SMA	1,443.8
3Y total return	49.77%
50-day SMA	1,283
50-day SMA vs 200-day SMA	50under200
5Y total return	58.51%
All Time High	1,702.1
All Time High Change	-20.8%
All Time High Date	2024-10-09
All Time Low	1.2
All Time Low Change	112,703.35%
All Time Low Date	1995-11-22
ATR	27.71
Beta	0.09
Beta1y	0.3
Beta2y	0.32
Ch YTD	-10.81
High	1,366.7
High52	1,673
High52 Date	2025-10-23
High52ch	-19.43%
Low	1,341.3
Low52	1,165.7
Low52 Date	2026-04-02
Low52ch	15.64%
Ma50ch	5.07%
Price vs 200-day SMA	-6.64%
RSI	64.21
RSI Monthly	46.96
RSI Weekly	46.34
Sharpe ratio	-0.7x
Sortino ratio	-0.68
Total Return	0.95%
Tr YTD	-10.81
Tr15y	382.95%
Tr1m	12.11%
Tr1w	0.97%
Tr3m	1.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 54.4B
Operating Income Growth	-8.3
Operating Income Growth Q	-42.85
Operating Income Growth3 Y	15.28
Operating Income Growth5 Y	12.26
Operating margin	19.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	563,383,357%
Shares Insiders	29.93%
Shares Institutions	46.67%
Shares Out	807,782,631
Shares Qo Q	0.03%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,846,896.8x
Bv Per Share	407.5
Ch10y	150.9
Ch15y	341.2
Ch1m	12.11
Ch1w	0.97
Ch1y	-10.66
Ch20y	389.2
Ch3m	1.35
Ch3y	45.76
Ch5y	52.68
Ch6m	-10.47
Change	-1.05%
Change From Open	-0.52
Close	1,362.3
Days Gap	-0.54
Depreciation Amortization	9,318,625,000
Dollar Volume	1,408,188,200
Earnings Date	2026-05-13
EBIT	INR 54.4B
EBITDA	INR 63.7B
EPS	INR 56.25
F Score	1
Fiscal Year End	March
Founded	1,935
Graham Number	720.0698
Graham Upside	-46.58
Income Tax	INR 14.8B
Is Primary Listing	1
Last Earnings Date	2026-01-23
Last Report Date	2025-12-31
Last Split Date	2006-04-24
Last Split Type	Forward
Lynch Fair Value	INR 858
Lynch Upside	-36.34
Ma150	1,411.4
Ma150ch	-4.49%
Ma20	1,282.8
Ma20ch	5.08%
Next Earnings Date	2026-05-13
Open	1,355
Payment Date	2025-08-15
Position In Range	26.38
Price Date	2026-05-08
Price EBITDA	INR 17.08
Ptbv Ratio	3.95
Relative Volume	0.54x
Revenue	279,671,900,000x
Tax By Revenue	5.28x
Tax Rate	24.56%
Tr20y	459.41%
Tr6m	-10.47%
Volume	1,044,650

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/CIPLA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$13.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+26.2%

3 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-06-27

Performance

NSE/CIPLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/CIPLA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.7%

Share of float held by funds and institutions

Insider ownership

+29.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/CIPLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.2

Neutral momentum band

Price vs 200-day MA

-6.6%

50/200-day relationship not available

Beta (5Y)

0.09

Less volatile than the market

Sharpe ratio

-0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/CIPLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/CIPLA stock rating?

nse/CIPLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/CIPLA analysis?

The full report lives at /stocks/nse/CIPLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/CIPLA?

The latest report frames nse/CIPLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/CIPLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.